questionsmedicales.fr
Thérapeutique
Radiothérapie
Radiothérapie : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Radiothérapie
Cancer
Diagnostic médical
Imagerie médicale
Radiothérapie
IRM
Oncologie
Radiothérapie
Médecin spécialiste
Cancer du sein
Cancer de la prostate
Radiothérapie
Radiothérapie
Prévention du cancer
Traitement du cancer
Symptômes
5
Effets secondaires
Radiothérapie
Symptômes
Nausées
Radiothérapie
Effets indésirables
Effets à long terme
Radiothérapie
Santé reproductive
Fatigue
Radiothérapie
Gestion des symptômes
Appétit
Radiothérapie
Effets secondaires
Prévention
5
Prévention du cancer
Radiothérapie
Traitement du cancer
Prévention du cancer
Mode de vie
Santé
Dépistage
Radiothérapie
Prévention du cancer
Vaccins
Prévention du cancer
HPV
Stress
Prévention du cancer
Santé mentale
Traitements
5
Radiothérapie externe
Curiethérapie
Radiothérapie
Chimiothérapie
Radiothérapie
Traitement combiné
Séances de traitement
Radiothérapie
Cancer
Douleur
Radiothérapie
Effets indésirables
Séance de radiothérapie
Radiothérapie
Procédure médicale
Complications
5
Complications
Radiothérapie
Effets indésirables
Cancers secondaires
Radiothérapie
Risques
Prévention
Complications
Suivi médical
Complications
Radiothérapie
Type de cancer
Soins post-traitement
Radiothérapie
Suivi médical
Facteurs de risque
5
Facteurs de risque
Cancer
Radiothérapie
Antécédents médicaux
Radiothérapie
Cancer
Sexe
Radiothérapie
Cancer
Alimentation
Facteurs de risque
Cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Radiothérapie : Questions médicales les plus fréquentes",
"headline": "Radiothérapie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Radiothérapie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-03",
"dateModified": "2025-04-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Radiothérapie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Thérapeutique",
"url": "https://questionsmedicales.fr/mesh/D013812",
"about": {
"@type": "MedicalCondition",
"name": "Thérapeutique",
"code": {
"@type": "MedicalCode",
"code": "D013812",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Curiethérapie",
"alternateName": "Brachytherapy",
"url": "https://questionsmedicales.fr/mesh/D001918",
"about": {
"@type": "MedicalCondition",
"name": "Curiethérapie",
"code": {
"@type": "MedicalCode",
"code": "D001918",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chimioradiothérapie",
"alternateName": "Chemoradiotherapy",
"url": "https://questionsmedicales.fr/mesh/D059248",
"about": {
"@type": "MedicalCondition",
"name": "Chimioradiothérapie",
"code": {
"@type": "MedicalCode",
"code": "D059248",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.160"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chimioradiothérapie adjuvante",
"alternateName": "Chemoradiotherapy, Adjuvant",
"url": "https://questionsmedicales.fr/mesh/D059186",
"about": {
"@type": "MedicalCondition",
"name": "Chimioradiothérapie adjuvante",
"code": {
"@type": "MedicalCode",
"code": "D059186",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.160.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Irradiation crânienne",
"alternateName": "Cranial Irradiation",
"url": "https://questionsmedicales.fr/mesh/D016371",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation crânienne",
"code": {
"@type": "MedicalCode",
"code": "D016371",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.190"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Irradiation hypophysaire",
"alternateName": "Pituitary Irradiation",
"url": "https://questionsmedicales.fr/mesh/D010910",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation hypophysaire",
"code": {
"@type": "MedicalCode",
"code": "D010910",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.190.600"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Irradiation craniospinale",
"alternateName": "Craniospinal Irradiation",
"url": "https://questionsmedicales.fr/mesh/D061888",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation craniospinale",
"code": {
"@type": "MedicalCode",
"code": "D061888",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.230"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie par ions lourds",
"alternateName": "Heavy Ion Radiotherapy",
"url": "https://questionsmedicales.fr/mesh/D063193",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie par ions lourds",
"code": {
"@type": "MedicalCode",
"code": "D063193",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protonthérapie",
"alternateName": "Proton Therapy",
"url": "https://questionsmedicales.fr/mesh/D061766",
"about": {
"@type": "MedicalCondition",
"name": "Protonthérapie",
"code": {
"@type": "MedicalCode",
"code": "D061766",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.250.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Irradiation hémicorporelle",
"alternateName": "Hemibody Irradiation",
"url": "https://questionsmedicales.fr/mesh/D017619",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation hémicorporelle",
"code": {
"@type": "MedicalCode",
"code": "D017619",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.270"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Irradiation ganglionnaire",
"alternateName": "Lymphatic Irradiation",
"url": "https://questionsmedicales.fr/mesh/D015182",
"about": {
"@type": "MedicalCondition",
"name": "Irradiation ganglionnaire",
"code": {
"@type": "MedicalCode",
"code": "D015182",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.350"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radioimmunothérapie",
"alternateName": "Radioimmunotherapy",
"url": "https://questionsmedicales.fr/mesh/D016499",
"about": {
"@type": "MedicalCondition",
"name": "Radioimmunothérapie",
"code": {
"@type": "MedicalCode",
"code": "D016499",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.520"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie adjuvante",
"alternateName": "Radiotherapy, Adjuvant",
"url": "https://questionsmedicales.fr/mesh/D018714",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie adjuvante",
"code": {
"@type": "MedicalCode",
"code": "D018714",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dosimétrie en radiothérapie",
"alternateName": "Radiotherapy Dosage",
"url": "https://questionsmedicales.fr/mesh/D011879",
"about": {
"@type": "MedicalCondition",
"name": "Dosimétrie en radiothérapie",
"code": {
"@type": "MedicalCode",
"code": "D011879",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Fractionnement de la dose d'irradiation",
"alternateName": "Dose Fractionation, Radiation",
"url": "https://questionsmedicales.fr/mesh/D019583",
"about": {
"@type": "MedicalCondition",
"name": "Fractionnement de la dose d'irradiation",
"code": {
"@type": "MedicalCode",
"code": "D019583",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hypofractionnement de dose",
"alternateName": "Radiation Dose Hypofractionation",
"url": "https://questionsmedicales.fr/mesh/D000069473",
"about": {
"@type": "MedicalCondition",
"name": "Hypofractionnement de dose",
"code": {
"@type": "MedicalCode",
"code": "D000069473",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Hypofractionnement de dose",
"alternateName": "Radiation Dose Hypofractionation",
"url": "https://questionsmedicales.fr/mesh/D000069473",
"about": {
"@type": "MedicalCondition",
"name": "Hypofractionnement de dose",
"code": {
"@type": "MedicalCode",
"code": "D000069473",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.639.200.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie de haute énergie",
"alternateName": "Radiotherapy, High-Energy",
"url": "https://questionsmedicales.fr/mesh/D011882",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie de haute énergie",
"code": {
"@type": "MedicalCode",
"code": "D011882",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie par capture de neutrons",
"alternateName": "Neutron Capture Therapy",
"url": "https://questionsmedicales.fr/mesh/D017247",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par capture de neutrons",
"code": {
"@type": "MedicalCode",
"code": "D017247",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Thérapie par capture de neutrons par le bore",
"alternateName": "Boron Neutron Capture Therapy",
"url": "https://questionsmedicales.fr/mesh/D016754",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par capture de neutrons par le bore",
"code": {
"@type": "MedicalCode",
"code": "D016754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.500.100"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Thérapie par capture de neutrons par le bore",
"alternateName": "Boron Neutron Capture Therapy",
"url": "https://questionsmedicales.fr/mesh/D016754",
"about": {
"@type": "MedicalCondition",
"name": "Thérapie par capture de neutrons par le bore",
"code": {
"@type": "MedicalCode",
"code": "D016754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.500.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Télégammathérapie",
"alternateName": "Radioisotope Teletherapy",
"url": "https://questionsmedicales.fr/mesh/D011867",
"about": {
"@type": "MedicalCondition",
"name": "Télégammathérapie",
"code": {
"@type": "MedicalCode",
"code": "D011867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.722.820"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie guidée par l'image",
"alternateName": "Radiotherapy, Image-Guided",
"url": "https://questionsmedicales.fr/mesh/D061089",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie guidée par l'image",
"code": {
"@type": "MedicalCode",
"code": "D061089",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.768"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Radiothérapie X",
"alternateName": "X-Ray Therapy",
"url": "https://questionsmedicales.fr/mesh/D014964",
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie X",
"code": {
"@type": "MedicalCode",
"code": "D014964",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.815.907"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Radiothérapie",
"alternateName": "Radiotherapy",
"code": {
"@type": "MedicalCode",
"code": "D011878",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "David R Raleigh",
"url": "https://questionsmedicales.fr/author/David%20R%20Raleigh",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. David.Raleigh@ucsf.edu."
}
},
{
"@type": "Person",
"name": "Baolin Qu",
"url": "https://questionsmedicales.fr/author/Baolin%20Qu",
"affiliation": {
"@type": "Organization",
"name": "Precision Medical Advanced Innovation Center, Beijing University of Aeronautics and Astronautics, Beijing, 100083."
}
},
{
"@type": "Person",
"name": "Gustavo Arruda Viani",
"url": "https://questionsmedicales.fr/author/Gustavo%20Arruda%20Viani",
"affiliation": {
"@type": "Organization",
"name": "Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP), Ribeirão Preto, SP, Brazil."
}
},
{
"@type": "Person",
"name": "P A Coucke",
"url": "https://questionsmedicales.fr/author/P%20A%20Coucke",
"affiliation": {
"@type": "Organization",
"name": "Service de Radiothérapie, CHU Liège, Belgique."
}
},
{
"@type": "Person",
"name": "William C Chen",
"url": "https://questionsmedicales.fr/author/William%20C%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94143, USA. william.chen@ucsf.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Incidence and mechanism of conjunctival chemosis during phacoemulsification.",
"datePublished": "2024-10-11",
"url": "https://questionsmedicales.fr/article/39394580",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12886-024-03670-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Changes in refraction after cataract phacoemulsification surgery.",
"datePublished": "2022-10-12",
"url": "https://questionsmedicales.fr/article/36223001",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10792-022-02550-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Microstent Implantation with Phacoemulsification Versus Phacoemulsification Alone for Patients with Open Angle Glaucoma: A Systematic Review and Meta-Analysis of Randomised Clinical Trials.",
"datePublished": "2022-06-06",
"url": "https://questionsmedicales.fr/article/35666616",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/08820538.2022.2086012"
}
},
{
"@type": "ScholarlyArticle",
"name": "Management of Suprachoroidal Hemorrhage during Phacoemulsification: A Comprehensive Review.",
"datePublished": "2023-03-15",
"url": "https://questionsmedicales.fr/article/36984584",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/medicina59030583"
}
},
{
"@type": "ScholarlyArticle",
"name": "Outcomes of Phacoemulsification With Toric Intraocular Lenses in Addressing Postkeratoplasty Astigmatism.",
"datePublished": "2023-04-25",
"url": "https://questionsmedicales.fr/article/37099688",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/ICO.0000000000003288"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Radiothérapie",
"item": "https://questionsmedicales.fr/mesh/D011878"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Radiothérapie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Radiothérapie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-04",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Radiothérapie",
"description": "Comment la radiothérapie est-elle diagnostiquée ?\nQuels examens précèdent la radiothérapie ?\nQui détermine le besoin de radiothérapie ?\nQuels types de cancers nécessitent la radiothérapie ?\nLa radiothérapie est-elle utilisée en prévention ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Phacoemulsification#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Radiothérapie",
"description": "Quels symptômes peuvent apparaître après la radiothérapie ?\nLa radiothérapie cause-t-elle des nausées ?\nY a-t-il des symptômes à long terme ?\nComment gérer la fatigue liée à la radiothérapie ?\nLa radiothérapie affecte-t-elle l'appétit ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Phacoemulsification#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Radiothérapie",
"description": "La radiothérapie peut-elle prévenir le cancer ?\nQuels modes de vie aident à prévenir le cancer ?\nLes dépistages aident-ils à éviter la radiothérapie ?\nLes vaccins peuvent-ils prévenir certains cancers ?\nLe stress influence-t-il le cancer ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Phacoemulsification#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Radiothérapie",
"description": "Quels types de radiothérapie existent ?\nLa radiothérapie est-elle combinée à d'autres traitements ?\nCombien de séances de radiothérapie sont nécessaires ?\nLa radiothérapie est-elle douloureuse ?\nComment se déroule une séance de radiothérapie ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Phacoemulsification#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Radiothérapie",
"description": "Quelles sont les complications possibles de la radiothérapie ?\nLa radiothérapie peut-elle causer des cancers secondaires ?\nComment prévenir les complications de la radiothérapie ?\nLes complications varient-elles selon le type de cancer ?\nQuels soins sont nécessaires après la radiothérapie ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Phacoemulsification#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Radiothérapie",
"description": "Quels sont les facteurs de risque pour le cancer traité par radiothérapie ?\nL'âge influence-t-il le besoin de radiothérapie ?\nLes antécédents médicaux influencent-ils la radiothérapie ?\nLe sexe joue-t-il un rôle dans le traitement par radiothérapie ?\nL'alimentation affecte-t-elle le risque de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D011878?mesh_terms=Phacoemulsification#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment la radiothérapie est-elle diagnostiquée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie n'est pas diagnostiquée, mais elle est prescrite après un diagnostic de cancer."
}
},
{
"@type": "Question",
"name": "Quels examens précèdent la radiothérapie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens d'imagerie comme le scanner ou l'IRM sont souvent réalisés avant la radiothérapie."
}
},
{
"@type": "Question",
"name": "Qui détermine le besoin de radiothérapie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un oncologue est responsable de l'évaluation et de la prescription de la radiothérapie."
}
},
{
"@type": "Question",
"name": "Quels types de cancers nécessitent la radiothérapie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie est couramment utilisée pour les cancers du sein, de la prostate et du poumon."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle utilisée en prévention ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la radiothérapie est un traitement curatif, pas préventif, pour les cancers diagnostiqués."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent apparaître après la radiothérapie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, rougeur de la peau et douleurs localisées selon la zone traitée."
}
},
{
"@type": "Question",
"name": "La radiothérapie cause-t-elle des nausées ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées peuvent survenir, surtout si la zone traitée est l'abdomen ou le cerveau."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes à long terme ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme peuvent inclure des changements cutanés ou des problèmes de fertilité."
}
},
{
"@type": "Question",
"name": "Comment gérer la fatigue liée à la radiothérapie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de se reposer, de bien s'hydrater et de suivre les conseils du médecin."
}
},
{
"@type": "Question",
"name": "La radiothérapie affecte-t-elle l'appétit ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent éprouver une perte d'appétit pendant le traitement."
}
},
{
"@type": "Question",
"name": "La radiothérapie peut-elle prévenir le cancer ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la radiothérapie est un traitement, pas un moyen de prévention du cancer."
}
},
{
"@type": "Question",
"name": "Quels modes de vie aident à prévenir le cancer ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine, l'exercice régulier et l'évitement du tabac peuvent aider à prévenir le cancer."
}
},
{
"@type": "Question",
"name": "Les dépistages aident-ils à éviter la radiothérapie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dépistages réguliers peuvent détecter le cancer tôt, réduisant ainsi le besoin de radiothérapie."
}
},
{
"@type": "Question",
"name": "Les vaccins peuvent-ils prévenir certains cancers ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des vaccins comme celui contre le HPV peuvent prévenir certains cancers, comme le cancer du col de l'utérus."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il le cancer ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress n'est pas un facteur direct, mais un mode de vie sain peut aider à réduire le risque."
}
},
{
"@type": "Question",
"name": "Quels types de radiothérapie existent ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux types sont la radiothérapie externe et la radiothérapie interne (curiethérapie)."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle combinée à d'autres traitements ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est souvent combinée avec la chimiothérapie ou la chirurgie pour une efficacité accrue."
}
},
{
"@type": "Question",
"name": "Combien de séances de radiothérapie sont nécessaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le nombre de séances varie selon le type de cancer, généralement entre 5 et 30 séances."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle douloureuse ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la radiothérapie elle-même n'est pas douloureuse, mais des effets secondaires peuvent l'être."
}
},
{
"@type": "Question",
"name": "Comment se déroule une séance de radiothérapie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le patient est positionné sur une table, et des rayons ciblés sont administrés sans douleur."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la radiothérapie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des lésions tissulaires, des infections et des effets secondaires à long terme."
}
},
{
"@type": "Question",
"name": "La radiothérapie peut-elle causer des cancers secondaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il existe un risque faible de développer des cancers secondaires après une radiothérapie."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications de la radiothérapie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et le respect des recommandations du médecin aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le type de cancer ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent varier selon la localisation et le type de cancer traité."
}
},
{
"@type": "Question",
"name": "Quels soins sont nécessaires après la radiothérapie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins de la peau, une bonne hydratation et un suivi médical sont essentiels après le traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour le cancer traité par radiothérapie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'exposition à des substances cancérigènes et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le besoin de radiothérapie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de cancer augmente avec l'âge, ce qui peut nécessiter une radiothérapie."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils la radiothérapie ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de cancer ou de radiothérapie peuvent influencer le traitement futur."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans le traitement par radiothérapie ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines cancers sont plus fréquents chez un sexe, influençant ainsi le besoin de radiothérapie."
}
},
{
"@type": "Question",
"name": "L'alimentation affecte-t-elle le risque de cancer ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en fruits et légumes peut réduire le risque de certains cancers."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 28/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA. David.Raleigh@ucsf.edu.
Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA. David.Raleigh@ucsf.edu.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Precision Medical Advanced Innovation Center, Beijing University of Aeronautics and Astronautics, Beijing, 100083.
Department of Radiotherapy, PLA General Hospital, Beijing, 100853.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP), Ribeirão Preto, SP, Brazil.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Service de Radiothérapie, CHU Liège, Belgique.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, 94143, USA. william.chen@ucsf.edu.
Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, 94143, USA. william.chen@ucsf.edu.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Johns Hopkins University, Baltimore, MD, 21287, USA.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, Ohio State University, Columbus, OH, 43210, USA.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Neurological Surgery, Northwestern University, Chicago, IL, 60611, USA.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Cancer Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, Jiangsu 404100, China.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Klinik für Strahlentherapie und Radioonkologie, Universitätsklinikum Münster, Gebäude A1, Albert Schweitzer Campus, 48149, Münster, Deutschland. hans.eich@ukmuenster.de.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, The Mayo Clinic, Rochester, MN, USA.
Publications dans "Radiothérapie" :
2 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
University Hospital for Tumors, Sestre milosrdnice University Hospital Center.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of Rochester, Rochester, NY 14642, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA 90095, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of Rochester, Rochester, NY 14642, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Radiation Oncology, University of Rochester, Rochester, NY 14642, USA.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Dept. of Radiation Oncology, Graduate School of Biomedical and Health Sciences, Hiroshima University.
Publications dans "Radiothérapie" :
1 publication dans cette catégorie
Affiliations :
Department of Liver Surgery and Liver Transplantation, State Key Laboratory of Biotherapy and Cancer Center, Sichuan University and Collaborative Innovation Center of Biotherapy, West China Hospital, Chengdu, Sichuan 610000, P.R. China.
Publications dans "Radiothérapie" :
This study aims to determine the incidence of conjunctival chemosis during phacoemulsification and to explore the possible mechanism and treatments....
Patients with or without chemosis during phacoemulsification by the same operator within two years were included. The initial site of chemosis, the chemosis originated time, and the degree of chemosis...
The incidence of intraoperative chemosis was 9.17% (66/720). The distance between CCI and the end of the Bowman's layer in the chemosis group was significantly longer than that in the non-chemosis gro...
Intraoperative chemosis is related to the distance from CCI to the end of Bowmen's layer. The residual conjunctiva around the incision wraps the phacoemulsification probe sleeve to form a passage, the...
After cataract phacoemulsification surgery, spherical equivalent refraction (SER) may be affected by factors including corneal curvature, effective lens position and axial length. While refractive out...
This was a retrospective observational study that included 344 eyes of 204 patients who underwent cataract emulsification surgery between 1 January and 31 December 2018 at two private hospitals. Kerat...
Between 1 month and 3 years post-operatively, an overall myopic shift (0.32 ± 0.21 D, p < 0.001) occurred in 33.6% of eyes and a hypermetropic shift in 45.2% of eyes (0.35 ± 0.22 D, p < 0.001). In 21....
The 3-year timeline changes in SER after cataract surgery were evaluated. As hypermetropic shift was the most common refractive change observed, it may be beneficial to aim for a more myopic post-oper...
The purpose of this meta-analysis is to systematically compare the IOP-lowering effect of different microstents combined with phacoemulsification versus phacoemulsification for patients with OAG and c...
This work was done through the data searched from PubMed, EMBASE, and the Cochrane Library. The Cochrane Handbook was also used to evaluate the quality of the included studies. In addition, this meta-...
A total of 8 randomized controlled trials (RCTs) were included. Compared with phacoemulsification alone, microstent implantation with phacoemulsification resulted in significant reduction in the posto...
Both microstent implantation with concurrent phacoemulsification and phacoemulsification alone result in a significant reduction in IOP. In terms of both reductions, microstent implantation with phaco...
Suprachoroidal hemorrhage (SCH) is a rare and sight-threatening complication of various intraocular surgeries, including cataract surgery. Although the rate of SCH complicating cataract surgery has de...
The aim of this study was to assess the short-term and long-term effectiveness of toric intraocular lenses (IOLs) as a treatment for significant postkeratoplasty astigmatism....
This was a retrospective case review study that analyzes postkeratoplasty eyes after phacoemulsification with toric IOL implantation....
Seventy-five eyes were included. Previous surgery was penetrating keratoplasty (50.6%), deep anterior lamellar keratoplasty (34.6%), or automated anterior lamellar therapeutic keratoplasty (14.6%). Th...
Phacoemulsification and toric IOL implantation can effectively reduce moderate to high postkeratoplasty astigmatism, with a corresponding significant visual improvement....
To describe real-world intraocular pressure (IOP) changes following stand-alone cataract surgery by comparing postoperative IOP to phakic fellow eyes....
Retrospective clinical cohort study....
A total of 1,334,868 patients (336,060 with glaucoma and 998,808 without glaucoma) in the IRIS® Registry (Intelligent Research in Sight) underwent stand-alone phacoemulsification from 1 January 2013 t...
Postoperative daily mean IOP was initially greater for surgical than for control eyes because of an early postoperative IOP spike. By postoperative day 13, postoperative daily mean IOP was significant...
Eyes both with and without glaucoma that underwent stand-alone phacoemulsification had a significant decrease in IOP through the 90-day postoperative period compared to baseline and phakic fellow eyes...
To compare unused phacoemulsification tips and those used different times with different techniques of cataract surgery (divide and conquer and chop), in vivo phacoemulsifications were performed with ...
The aim of this study was to estimate the efficacy of the 8-chop technique in phacoemulsification surgeries of patients with cataract....
Sato Eye Clinic, Chiba-ken, Japan....
Prospective study....
Patients were classified into 3 groups (Grade II, Grade III, and Grade IV; n = 50 each) according to the firmness of their lens nuclei. The Eight-chopper I was used for Grade II, Eight-chopper II for ...
150 cataract surgeries were performed. The operative time (minutes), phaco time (seconds), CDE, and volume of fluid used (milliliters) differed significantly among the 3 groups, increasing in the foll...
The 8-chop technique was effective and safe in phacoemulsification for patients with cataracts with lens nuclei of varying hardness....
To observe the changes in corneal thickness during phacoemulsification cataract surgery and to analyze the influencing factors....
One hundred two patients (102 eyes) with cataracts undergoing phacoemulsification cataract surgery at Shandong Eye Hospital between July and October 2021 were included. Intraoperative OCT was applied ...
The corneal thickness of 102 cataract patients was 511.79 ± 31.46 μm before operation and 512.71 ± 31.51 μm at the beginning of phacoemulsification, which increased by 0.91 ± 1.48 μm (0.2%). At the en...
During phacoemulsification cataract surgery, corneal thickness gradually increases in real time with the increase of perfusion pressure and intraocular manipulation time. The real-time magnitude of in...
To explore ocular characteristics of patients with cataracts after renal transplantation and analyze the results of phacoemulsification combined with intraocular lens (IOL) implantation....
Patients with cataracts after renal transplantation and control patients who underwent phacoemulsification combined with IOL implantation were enrolled. All patients underwent phacoemulsification comb...
We analyzed 25 eyes of 16 patients after renal transplantation and 30 eyes of 21 control patients. The most common type of cataract of renal transplantation group was posterior subcapsular, while the ...
This study showed that cataracts after renal transplantation were mostly posterior subcapsular. Postoperative visual acuity recovered well in most patients, with reduced incidence of postoperative com...